Diane P. Goyette
FDA investigator
Appears on 1 document from 2017, mostly at sites in South Carolina. Most often cites drugs; name and place of business of manufacturer, packer, or distributor (21 CFR 201.1).
- 1
- Documents on file
- 4.0
- Observations per 483
- 2017
- First seen
- 2017
- Most recent
What they cite most
From 4 observations- 21 CFR 201.1Drugs; name and place of business of manufacturer, packer, or distributor1
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.160General requirements1
- 21 CFR 211.22Responsibilities of quality control unit1
Activity by year
2017: 1
Where
South Carolina 1
Often inspects with
Is Diane P. Goyette coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2017-04-21 | 483 Nephron Pharmaceuticals CorporationApr 21, 2017 · West Columbia, South Carolina | West Columbia, South Carolina | 4 |
About this profile
What does Diane P. Goyette inspect?
Diane P. Goyette appears on 1 document on file covering 1 site, mostly in South Carolina.
What do they cite most often?
21 CFR 201.1 (drugs; name and place of business of manufacturer, packer, or distributor), followed by 21 CFR 211.113 and 21 CFR 211.160.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Diane P. Goyette is dated Apr 21, 2017.